Appearance modeling of 11C PiB PET images: Characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging

被引:71
作者
Fripp, Jurgen [1 ]
Bourgeat, Pierrick [1 ]
Acosta, Oscar [1 ]
Raniga, Parnesh [1 ,2 ]
Modat, Marc [1 ,3 ]
Pike, Kerryn E. [4 ,5 ,6 ,7 ]
Jones, Gareth [4 ,5 ,6 ]
O'Keefe, Graeme [4 ,5 ,6 ]
Masters, Colin L. [7 ,8 ]
Ames, David [9 ]
Ellis, Kathryn A. [7 ,9 ]
Maruff, Paul [7 ,8 ,10 ]
Currie, Jon [7 ]
Villemagne, Victor L. [4 ,5 ,6 ,7 ]
Rowe, Christopher C. [4 ,5 ,6 ]
Salvado, Olivier [1 ]
Ourselin, Sebastien [1 ,3 ]
机构
[1] CSIRO, ICT Ctr, Australian eHlth Res Ctr, Brisbane, Qld, Australia
[2] Univ Sydney, Elect & Informat Engn Dept, Sydney, NSW 2006, Australia
[3] UCL, Ctr Med Image Comp, London, England
[4] Univ Melbourne, Austin Hosp, Dept Nucl Med, Melbourne, Vic, Australia
[5] Univ Melbourne, Austin Hosp, Ctr PET, Melbourne, Vic, Australia
[6] Univ Melbourne, Austin Hosp, Dept Med, Melbourne, Vic, Australia
[7] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3052, Australia
[8] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia
[9] Natl Ageing Res Inst, Parkville, Vic, Australia
[10] Cogstate Pty Ltd, Melbourne, Vic, Australia
关键词
C-11 PiB PET; Alzheimer's; Mild cognitive impairment; Appearance modeling; Principal component analysis; Eigen analysis; Spatial normalization;
D O I
10.1016/j.neuroimage.2008.07.053
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
beta-amyloid (A beta) deposition is one of the neuropathological hallmarks of Alzheimer's disease (AD), A beta burden can be quantified using C-11 PiB PET. Neuropathological studies have shown that the initial plaques are located in the temporal and orbitofrontal cortices, extending later to the cingulate, frontal and parietal cortices (Braak and Braak, 1997). Previous studies have shown an overlap in C-11 PiB PET retention between AD, mild cognitive impairment (MCI) patients and normal elderly control (NC) participants. It has also been shown that there is a relationship between A beta deposition and memory impairment in MCI patients. In this paper we explored the variability seen in 15 AD, 15 MCI and 18 NC by modeling the voxel data from spatially and uptake normalized PiB images using principal component analysis. The first two principal components accounted for 80% of the variability seen in the data, providing a clear separation between AD and NC, and allowing subsequent classification. The MCI cases were distributed along an apparent axis between the AD and NC group, closely aligned with the first principal component axis. The NC cases that were PiB(+) formed a distinct cluster that was between, but separated from the AD and PiB(-)NC clusters. The PiB(+) MCI were found to cluster with the AD cases, and exhibited a similar deposition pattern. The primary principal component score was found to correlate with episodic memory scores and mini mental status examination and it was observed that by varying the first principal component, a change in amyloid deposition could be derived that is similar to the expected progression of amyloid deposition observed from post mortem studies. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:430 / 439
页数:10
相关论文
共 43 条
[1]  
Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO
[2]  
2-G
[3]   Frequency of stages of Alzheimer-related lesions in different age categories [J].
Braak, H ;
Braak, E .
NEUROBIOLOGY OF AGING, 1997, 18 (04) :351-357
[4]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[5]   A row-action alternative to the EM algorithm for maximizing likelihoods in emission tomography [J].
Browne, J ;
DePierro, AR .
IEEE TRANSACTIONS ON MEDICAL IMAGING, 1996, 15 (05) :687-699
[6]   Design and construction of a realistic digital brain phantom [J].
Collins, DL ;
Zijdenbos, AP ;
Kollokian, V ;
Sled, JG ;
Kabani, NJ ;
Holmes, CJ ;
Evans, AC .
IEEE TRANSACTIONS ON MEDICAL IMAGING, 1998, 17 (03) :463-468
[7]   PET network abnormalities and cognitive decline in patients with mild cognitive impairment [J].
Devanand, Davangere P. ;
Habeck, Christian G. ;
Tabert, Matthias H. ;
Scarmeas, Nikolaos ;
Pelton, Gregory H. ;
Moeller, James R. ;
Mensh, Brett D. ;
Tarabula, Tyler ;
Van Heertum, Ronald L. ;
Stern, Yaakov .
NEUROPSYCHOPHARMACOLOGY, 2006, 31 (06) :1327-1334
[8]   Amyloid, hypometabolism, and cognition in Alzheimer disease - An [11C]PIB and [18F]FDG PET study [J].
Edison, P. ;
Archer, H. A. ;
Hinz, R. ;
Hammers, A. ;
Pavese, N. ;
Tai, Y. F. ;
Hotton, G. ;
Cutler, D. ;
Fox, N. ;
Kennedy, A. ;
Rossor, M. ;
Brooks, D. J. .
NEUROLOGY, 2007, 68 (07) :501-508
[9]   Two-year follow-up of amyloid deposition in patients with Alzheimer's disease [J].
Engler, Henry ;
Forsberg, Anton ;
Almkvist, Ove ;
Blomquist, Gunnar ;
Larsson, Emma ;
Savitcheva, Irina ;
Wall, Anders ;
Ringheim, Anna ;
Langstrom, Bengt ;
Nordberg, Agneta .
BRAIN, 2006, 129 :2856-2866
[10]   Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment [J].
Fleisher, A. S. ;
Sowell, B. B. ;
Taylor, C. ;
Gamst, A. C. ;
Petersen, R. C. ;
Thal, L. J. .
NEUROLOGY, 2007, 68 (19) :1588-1595